Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth arrest specific 2 like 1 pseudogene 2 (GAS2L1P2) is a human pseudogene, meaning it is a non-functional genomic segment derived from the functional GAS2L1 gene, itself part of the GAS2 protein family involved in cytoskeleton regulation and cell growth. Unlike its protein-coding relatives (GAS2, GAS2L1, GAS2L2, and GAS2L3), GAS2L1P2 does not produce a protein product and is not recognized as having conventional biological activity. Pseudogenes can sometimes regulate gene expression by producing RNA, acting as microRNA sponges, or generating siRNAs, but no explicit regulatory function or disease relevance has been proven for GAS2L1P2[3][5]. It is not a known receptor, enzyme, transporter, or therapeutic target. If there is confusion about its relevance, note that it should not be selected as a therapeutic target or clinical biomarker based on current knowledge. Summary of classification: GAS2L1P2 is a pseudogene and not a molecular target for therapy, drug screening, biomarker profiling, or disease association as of current scientific data[1][5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth arrest specific 2 like 1 pseudogene 2 (GAS2L1P2).